British Thoracic Society guideline for non-CF bronchiectasis

The diagnosis, investigation and particularly management of bronchiectasis has been largely empirical and the subject of relatively few controlled clinical trials. There are no clear guidelines, although an Australian position statement has been published concerning bronchiectasis in children. The p...

Full description

Saved in:
Bibliographic Details
Published inThorax Vol. 65 Suppl 1; p. i1
Main Authors Pasteur, M C, Bilton, D, Hill, A T
Format Journal Article
LanguageEnglish
Published England 01.07.2010
Subjects
Administration, Inhalation
Adult
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - therapeutic use
Bronchiectasis - diagnosis
Bronchiectasis - etiology
Bronchiectasis - therapy
Child
Cystic Fibrosis - complications
Diagnostic Techniques, Respiratory System
Evidence-Based Medicine
Humans
Infusions, Intravenous
Nebulizers and Vaporizers
Physical Therapy Modalities
Respiratory Function Tests
Respiratory System Agents - therapeutic use
Tomography, X-Ray Computed
Online AccessGet full text

Cover

More Information
Summary:The diagnosis, investigation and particularly management of bronchiectasis has been largely empirical and the subject of relatively few controlled clinical trials. There are no clear guidelines, although an Australian position statement has been published concerning bronchiectasis in children. The purposes of these guidelines were therefore threefold: (1) to identify relevant studies in non-cystic fibrosis (CF) bronchiectasis; (2) to provide guidelines on management based on published studies where possible or a consensus view; and (3) to identify gaps in our knowledge and identify areas for future study.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
ObjectType-Review-4
content type line 23
ISSN:1468-3296
1468-3296
DOI:10.1136/thx.2010.136119